Macfarlanes advises GP Investments on c. £100m block trade

09 July 2019

Macfarlanes has advised funds managed by GP Investments on a secondary placing of shares in FTSE 250 global supplier of refractory products, systems and services, RHI Magnesita. The transaction raised gross proceeds of c. £100m.

GP Investments is a listed company with permanent and patient capital with an industrial approach, focusing on accelerating value creation through direct investments and private equity fund management.

The Macfarlanes team for this matter was led by corporate and M&A partner Justin Hope, with assistance from senior counsel Mark Slade.

Justin Hope comments: "We were pleased to advise GP Investments on this substantial cross-border transaction, which has allowed funds managed by GP Investments to dispose of a significant stake in RHI Magnesita before the summer window for ECM transactions closes."